Faber, Edgar <br/><br/>
Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting.  [electronic resource] 

 -  Annals of hematology  Jun 2012 
 - 923-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-011-1394-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--analysis<br/>Benzamides<br/>Biomarkers, Pharmacological--analysis<br/>Blood Chemical Analysis<br/>Clinical Laboratory Techniques<br/>Diagnostic Tests, Routine<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood<br/>Male<br/>Middle Aged<br/>Piperazines--analysis<br/>Predictive Value of Tests<br/>Prognosis<br/>Pyrimidines--analysis<br/>Retrospective Studies<br/>Treatment Outcome<br/>Young Adult